Charles Schwab’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.48M Sell
355,896
-769
-0.2% -$7.59K ﹤0.01% 2617
2026
Q1
$3.47M Sell
356,665
-670
-0.2% -$6.14K ﹤0.01% 2550
2025
Q4
$3.41M Buy
357,335
+6,514
+2% +$66.3K ﹤0.01% 2596
2025
Q3
$3.42M Buy
350,821
+75,737
+28% +$582K ﹤0.01% 2589
2025
Q2
$1.67M Sell
275,084
-44,523
-14% -$334K ﹤0.01% 2725
2025
Q1
$3.96M Sell
319,607
-7,544
-2% -$107K ﹤0.01% 2372
2024
Q4
$4.53M Buy
327,151
+2,189
+0.7% +$34.5K ﹤0.01% 2372
2024
Q3
$5.44M Sell
324,962
-2,177
-0.7% -$46.8K ﹤0.01% 2331
2024
Q2
$6.75M Buy
327,139
+8,234
+3% +$178K ﹤0.01% 2219
2024
Q1
$7.9M Buy
318,905
+5,675
+2% +$169K ﹤0.01% 2102
2023
Q4
$11.4M Buy
313,230
+4,693
+2% +$181K ﹤0.01% 1917
2023
Q3
$14.9M Sell
308,537
-3,946
-1% -$234K ﹤0.01% 1687
2023
Q2
$21.3M Buy
312,483
+13,512
+5% +$872K 0.01% 1458
2023
Q1
$14.5M Sell
298,971
-1,879
-0.6% -$99.3K ﹤0.01% 1687
2022
Q4
$18.1M Buy
300,850
+15,108
+5% +$885K 0.01% 1508
2022
Q3
$17.3M Buy
285,742
+8,267
+3% +$261K 0.01% 1482
2022
Q2
$7.53M Sell
277,475
-6,927
-2% -$203K ﹤0.01% 1987
2022
Q1
$10.4M Buy
284,402
+28,788
+11% +$1.04M ﹤0.01% 1936
2021
Q4
$12.6M Buy
255,614
+13,899
+6% +$771K ﹤0.01% 1880
2021
Q3
$17.2M Buy
241,715
+34,889
+17% +$2.17M 0.01% 1698
2021
Q2
$10.6M Buy
206,826
+20,435
+11% +$638K ﹤0.01% 1962
2021
Q1
$4.68M Buy
186,391
+3,852
+2% +$72.5K ﹤0.01% 2335
2020
Q4
$2.19M Sell
182,539
-422
-0.2% -$4.99K ﹤0.01% 2569
2020
Q3
$1.83M Sell
182,961
-54,627
-23% -$657K ﹤0.01% 2517
2020
Q2
$2.49M Sell
237,588
-4,818
-2% -$53.5K ﹤0.01% 2345
2020
Q1
$2.59M Buy
242,406
+3,400
+1% +$41.2K ﹤0.01% 2160
2019
Q4
$3.78M Buy
239,006
+5,390
+2% +$57.8K ﹤0.01% 2171
2019
Q3
$1.83M Sell
233,616
-724
-0.3% -$6.43K ﹤0.01% 2405
2019
Q2
$2.48M Buy
234,340
+15,301
+7% +$157K ﹤0.01% 2299
2019
Q1
$2.66M Sell
219,039
-1,230
-0.6% -$15.4K ﹤0.01% 2264
2018
Q4
$2.27M Buy
220,269
+18,879
+9% +$224K ﹤0.01% 2287
2018
Q3
$2.63M Sell
201,390
-3,397
-2% -$49.1K ﹤0.01% 2343
2018
Q2
$2.99M Buy
204,787
+29,533
+17% +$583K ﹤0.01% 2245
2018
Q1
$6.43M Sell
175,254
-6,625
-4% -$241K 0.01% 1799
2017
Q4
$6.82M Buy
181,879
+9,301
+5% +$474K 0.01% 1743
2017
Q3
$11.2M Buy
172,578
+8,897
+5% +$545K 0.01% 1343
2017
Q2
$8.86M Buy
163,681
+9,824
+6% +$523K 0.01% 1444
2017
Q1
$8.58M Buy
153,857
+16,665
+12% +$876K 0.01% 1417
2016
Q4
$6.75M Buy
137,192
+7,046
+5% +$389K 0.01% 1543
2016
Q3
$7.8M Buy
130,146
+17,784
+16% +$954K 0.01% 1345
2016
Q2
$3.93M Sell
112,362
-6,130
-5% -$267K ﹤0.01% 1716
2016
Q1
$4.88M Buy
118,492
+10,626
+10% +$416K 0.01% 1534
2015
Q4
$7.35M Buy
107,866
+15,006
+16% +$905K 0.01% 1243
2015
Q3
$4.21M Buy
92,860
+38,088
+70% +$2.22M 0.01% 1584
2015
Q2
$2.88M Buy
54,772
+6,469
+13% +$255K ﹤0.01% 1891
2015
Q1
$1.84M Hold
48,303
﹤0.01% 2096
2014
Q4
$1M Hold
48,303
﹤0.01% 2353
2014
Q3
$1.07M Buy
48,303
+16,203
+50% +$344K ﹤0.01% 2264
2014
Q2
$724K Buy
32,100
+11,600
+57% +$290K ﹤0.01% 2483
2014
Q1
$786K Hold
20,500
﹤0.01% 2400
2013
Q4
$544K Buy
20,500
+3,600
+21% +$90.3K ﹤0.01% 2561
2013
Q3
$339K Hold
16,900
﹤0.01% 2702
2013
Q2
$220K Buy
+16,900
New +$157K ﹤0.01% 2858

Other funds holding PRTA

Charles Schwab's PRTA Position: Q2 2026 in Review

Charles Schwab reduced its Prothena Corp (PRTA) stake by 0.22% in Q2 2026, selling an estimated $7.59K and leaving 355,896 shares worth $3.48M. The position accounts for ﹤0.01% of the portfolio, ranked #2617.

Charles Schwab first reported a position in PRTA in Q2 2013 and has held it in 53 quarters since. The position peaked at $21.3M in Q2 2023. 188 funds tracked by Wall St. Rank hold PRTA as of Q2 2026.

  • Charles Schwab held 355,896 shares of Prothena Corp worth $3.48M as of Q2 2026.
  • Charles Schwab sold 769 Prothena Corp shares in Q2 2026, an estimated $7.59K.
  • Prothena Corp made up ﹤0.01% of Charles Schwab's portfolio in Q2 2026, its #2617 holding.
  • Charles Schwab first reported a position in Prothena Corp in Q2 2013 and has held it in 53 quarters since.
  • Charles Schwab's Prothena Corp position peaked at $21.3M in Q2 2023.
  • 188 funds tracked by Wall St. Rank held Prothena Corp as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.